| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026717A2 Hydroxy acid integrin antagonists |
| 04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | WO2002026277A2 Stabilized hydrogen peroxide solutions |
| 04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
| 04/04/2002 | WO2002026234A1 Eye drops comprising acyclovir suspension |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | WO2002026223A2 Catecholamine pharmaceutical compositions and methods |
| 04/04/2002 | WO2002026219A2 Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 04/04/2002 | WO2001093893A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 04/04/2002 | WO2001060350A3 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 04/04/2002 | WO2001058494A3 Gene therapy for treating ocular-related disorders |
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | US20020040205 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040042 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
| 04/04/2002 | US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040015 Administering to the mammal an anti-angiogenesis factor and a photosensitizer to permit to localize in the chorodial neovasculature, irradiating the chorodial neovasculature with laser light |
| 04/04/2002 | US20020040007 Novel macrolide antibiotics |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | DE10046838A1 Verwendung von Myxoxanthophyll und/oder Echinenon zur prophylaktischen und/oder therapeutischen Behandlung von unerwünschten, durch oxidative Prozesse bedingten oder begünstigten körperlichen Zuständen Use of Myxoxanthophyll and / or echinenone for prophylactic and / or therapeutic treatment of unwanted situations due to oxidative processes beneficiary physical conditions |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/04/2002 | CA2425749A1 Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
| 04/04/2002 | CA2424021A1 Catecholamine compositions and uses thereof |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423474A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | CA2423464A1 Hydroxy acid integrin antagonists |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | CA2423201A1 Stabilized hydrogen peroxide solutions |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 04/04/2002 | CA2420672A1 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/03/2002 | EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| 04/03/2002 | EP1193267A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192947A1 Pharmaceutical composition comprising trehalose for ophthalmic use |
| 04/03/2002 | EP1192946A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192163A1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 04/03/2002 | EP1192158A2 Substituted 8-phenylxanthines useful as antagonists of a 2b? adenosine receptors |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1191943A1 Novel anti-allergic agents |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 04/03/2002 | EP0853476B1 Pharmaceutical preparation containing nimesulide for topical use |
| 04/03/2002 | EP0716600B1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 04/03/2002 | CN1343122A Remedies for joint diseases |
| 04/03/2002 | CN1342651A Ganciclovir sodium hydrate and its preparing process and application |
| 04/03/2002 | CN1342494A Ear drops for repairing ear membrane |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365612 Benzosultam oxazolidinone antibacterial agents |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | CA2357929A1 Nmda nr2b antagonists for the treatment of depression |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2002024697A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024659A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
| 03/28/2002 | WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024657A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024639A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2002024250A1 Use of inos inhibitors for treating or preventing myopia |
| 03/28/2002 | WO2002024226A2 Photosensitisers |
| 03/28/2002 | WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections |
| 03/28/2002 | WO2002024207A1 Diuretic or sulphonylurea for use in antiviral treatment |
| 03/28/2002 | WO2002024187A2 Treatment of diseases with adamantane derivatives |
| 03/28/2002 | WO2002024183A1 Use of myxoxanthophyll and/or echinenone for the prophylactic and/or therapeutic treatment of undesirable physical conditions conditioned or favoured by oxidative processes |